Ketoconazole doubles the AUC of
rimonabant. Other drugs that are potent inhibitors of CYP3A4, such as
ritonavir, are predicted to interact similarly.
The manufacturers of
rimonabant recommend caution. Monitor for signs of increased
rimonabant adverse effects.